首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 72 毫秒
1.
从9月份采集的野生药用植物蛇足石杉(Huperzia serrata)的茎、叶中分离纯化得到15株内生真菌,将上述内生真菌进行液体培养后,通过薄层层析法(TLC)和高效液相法(HPLC)对其代谢产物进行检测,结果表明菌株WX13产石杉碱甲(Huperzine A,HupA)。运用形态和培养特性观察,初步确定菌株WX13属于镰刀菌属(Fu-sarium sp.)。  相似文献   

2.
为了获取具有应用价值的产石杉碱甲内生菌,本文从蛇足石杉分离得到60株内生真菌,采用高效液相色谱法和质谱法分别检测各个真菌的提取物,发现内生真菌SNZ-12的提取物具有与石杉碱甲标品相近的色谱特征峰和保留时间(8. 994 min)以及相同的质谱特征峰((M+H)+=243. 1),说明内生真菌SNZ-12可以产石杉碱甲,其石杉碱甲产量约为1. 01 mg/L;并通过结合内生真菌SNZ-12的形态特征和18S r DNA序列分析,将其鉴定为尖孢镰刀菌(Fusarium oxysporum)。本文结果为利用微生物发酵生产石杉碱甲研究提供了潜在的菌种资源。  相似文献   

3.
从蛇足石杉中超声提取石杉碱甲和石杉碱乙   总被引:11,自引:1,他引:11  
用正交试验确立了超声提取蛇足石杉生物碱的最佳条件。以石杉碱甲和石杉碱乙回收率为指标,考察了溶剂倍数、溶剂浓度、超声时间、超声功率等因素的影响。结果表明,在室温下超声提取的最优条件为:酸浓度O.8%(v/v),液固比例20:1,超声功率600W,超声15min。三次重复实验所得石杉碱甲和石杉碱乙回收率分别是9r7.3%和93.5%,相对标准偏差分别为1.31%和1.40%(n=3)。与传统的回流提取工艺相比,过程时间从2h缩短为15min,回收率提高了10%以上。  相似文献   

4.
杜次  彭清忠  田向荣  朱越  李菁 《广西植物》2013,33(3):406-409
采用超声萃取法提取湘西蛇足石杉总生物碱,用高效液相色谱法同时测定其石杉碱甲、乙和丙含量,并分析其在植株不同部位的分布。结果表明:湘西4个样地蛇足石杉中石杉碱甲、乙和丙含量基本一致,分别达到0.5‰、0.3‰和0.04‰;但植株不同部位三种石杉碱含量差异显著,其中石杉碱甲和乙的分布均为叶>茎>根,石杉碱丙则是根大于叶和茎。由此可知,湘西蛇足石杉具有资源优势,石杉碱在植株的分布具有明显的部位选择性;采用HPLC可同时检测石杉碱甲、乙和丙,方法简单快速、准确可靠。  相似文献   

5.
【目的】从野生蛇足石杉(Huperzia serrata)中分离筛选产石杉碱甲的内生真菌。【方法】采用薄层层析及高效液相色谱法对内生真菌代谢产物进行测定和分析以期分离获得产石杉碱甲菌株,运用形态及ITS序列分析方法对产石杉碱甲菌株进行鉴定,并利用连续传代方法考察菌株遗传稳定性。【结果】经筛选获得一株产石杉碱甲内生真菌NSH-5,经形态学鉴定及ITS序列分析鉴定为轮枝镰孢菌(Fusarium verticillioides),其石杉碱甲产量为11.76 mg/100 m L,菌株经20次连续传代后遗传稳定。【结论】NSH-5菌株为一株具有产石杉碱甲能力的轮枝镰孢菌,该菌株的发现为生物合成石杉碱甲提供了新的菌种资源。  相似文献   

6.
为了解浅层液体培养对蛇足石杉[Huperzia serrate (Thunb.) Trev.]叶状体的影响,采用不同用量培养液进行培养,对叶状体的生长、石杉碱甲(HupA)积累、抗氧化酶活性和内源激素的变化进行了研究。结果表明,培养液用量不同,叶状体产生的HupA含量有显著差异,15 mL浅层培养的HupA生产率可达3 115.159μg L–1,是对照的2.20倍。浅层液体培养的叶状体的超氧化物歧化酶活性始终高于对照,过氧化物酶活性在培养前期比对照提高,过氧化氢酶活性在培养后期比对照提高;内源激素IAA与GA含量低于对照,而ABA含量高于对照。因此,浅层液体培养的蛇足石杉离体叶状体生产HupA的能力更高,且HupA含量与内源激素ABA水平相关,叶状体生长期的3种抗氧化酶活性具有协作增强抗氧化作用。  相似文献   

7.
以蛇足石杉孢子囊为材料培养得到蛇足石杉原叶体,进一步对原叶体进行增殖培养并诱导产生蛇足石杉孢子体。结果表明,适合蛇足石杉原叶体增殖的培养基是无激素的MS培养基,在该培养基上培养60d,原叶体的增殖倍数达到131.1;较高浓度的外源激素对原叶体的增殖有抑制作用,而低浓度的外源激素对原叶体的增殖影响不大;原叶体在无激素培养基上培养90d,孢子体的诱导频率为4.0%;通过HPLC检测蛇足石杉原叶体中石杉碱甲的含量为0.0059%,是野生孢子体中含量的0.25倍。  相似文献   

8.
湘西地区蛇足石杉内生真菌的分离   总被引:3,自引:0,他引:3  
采集不同生境的药用植物蛇足石杉,运用不同灭菌方法处理外植体,并用PDA平板培养基及孟加拉红培养基进行内生真菌的分离纯化.经过几种灭菌方法的摸索和比较研究,发现蛇足石杉外植体的灭菌十分困难(尤其是其茎部),难以在保持植物鲜活状态下达到一次彻底灭菌,有必要二次灭菌.通过二次灭菌分离得到的9株内生真菌中,来自蛇足石杉茎部的6株,来自叶片的3株.蛇足石杉的9株内生真菌在平板培养时生长极其缓慢,仅一株可在培养时产生孢子.  相似文献   

9.
从蛇足石杉(Huperzia serrata)叶片中分离到一株对小麦赤霉(Fusarium graminearum)等多种植物病原真菌有强拮抗作用的内生细菌H-6。通过形态和培养特性观察、生理生化实验及16S rDNA序列分析, 初步鉴定该菌属于伯克霍尔德属, 命名为Burkholderia sp. H-6。同时还对该菌培养条件进行了优化, 得出马铃薯浸出液中添加2.5%的甘露醇和0.1% NaNO3有利于细胞生长和抑菌活性的产生, 最适培养温度为28℃, 最佳初始pH4.0。  相似文献   

10.
从千层塔中分离产石杉碱甲内生真菌。采用平板分离法分离千层塔内生真菌,通过抑制乙酰胆碱酯酶活性和抗氧化活性筛选,结合薄层层析和HPLC测定活性菌株中的石杉碱甲含量,通过形态学ITS-rDNA序列分析鉴定内生真菌。共分离得到94株内生真菌,筛选到S29、L44、S94共3株乙酰胆碱酯酶抑制活性和清除DPPH·自由基活性都在50%以上,筛选到一株S29能产石杉碱甲的菌株。摇瓶发酵产量为每克干菌体的石杉碱甲含量为50.64μg。形态学与ITS-rDNA序列分析法鉴定该内生真菌为Podospora sp.属。药用植物千层塔体内Podospora sp.属的内生真菌可产石杉碱甲。  相似文献   

11.
为了确定九华山千层塔[Huperzia serrata(Thunb.)Trev.]的最佳采收期和采收部位,根据千层塔不同部位的石杉碱甲含量及各环境因子的变化趋势,运用灰色关联分析法对影响九华山千层塔石杉碱甲含量的主要环境因子进行了分析。结果表明,千层塔各部位的石杉碱甲含量不同,其中根中的含量最低,叶和茎中的含量较高;4月份叶和茎中的石杉碱甲含量最高,分别为0.0559%和0.0444%。影响九华山千层塔石杉碱甲含量的主要环境因子是根际土壤有机质含量、全氮含量和全磷含量,温度和降水量与石杉碱甲含量变化的相关性最小。研究结果表明,在九华山,千层塔的最佳采收期为4月份,最佳采收部位是叶和茎。  相似文献   

12.
在马铃薯葡萄糖液体培养基(PDB)、沙氏液体培养基(SDB)和查氏液体培养基(CDB)中发酵培养蛇足石杉内生真菌菌株SF88和LF52,乙酰胆碱酯酶(AChE)抑制活性检测结果表明,菌株SF88和LF52在PDB、SDB和CDB发酵后菌体总生物碱对AChE活性的抑制率分别为45.6%和56.7%、56.3%和68.5%、40.8%和48.3%。对这两株不产孢内生真菌的DNA ITS、18S rDNA、28S rDNA、TUB和RPB进行了测序,系统发育分析表明,SF88和LF52为Phaeosphaeriaceae科中一未知种,为开发生物碱类乙酰胆碱酯酶抑制剂(AChEI)药物提供了新的潜在菌种资源。  相似文献   

13.
Aims: To characterize and identify a novel Huperzine A (HupA)‐producing fungal strain Slf14 isolated from Huperzia serrata (Thunb. ex Murray) Trev. in China. Methods and Results: The isolation, identification and characterization of a novel endophytic fungus producing HupA specifically and consistently from the leaves of H. serrata were investigated. The fungus was identified as Shiraia sp. Slf14 by molecular and morphological methods. The HupA produced by this endophytic fungus was shown to be identical to authentic HupA analysed by thin layer chromatographic, High‐performance liquid chromatography (HPLC), LC‐MS, 1H NMR and acetylcholinesterase (AChE) inhibition activity in vitro. The amount of HupA produced by Shiraia sp. Slf14 was quantified to be 327·8 μg l?1 by HPLC, which was far higher than that of the reported endophytic fungi, Acremonium sp., Blastomyces sp. and Botrytis sp. Conclusions: The production of HupA by endophyte Shiraia sp. Slf14 is an enigmatic observation. It would be interesting to further study the HupA production and regulation by the cultured endophyte in H. serrata and in axenic cultures. Significance and Impact of the Study: Although the current accumulation of HupA by the endophyte is not very high, it could provide a promising alterative approach for large‐scale production of HupA. However, further strain improvement and the fermentation process optimization are required to result in the consistent and dependable production.  相似文献   

14.
采用形态学及ITS-rDNA序列分析法,对具有抑制乙酰胆碱酯酶活性的蛇足石杉内生菌株JR14进行鉴定,确定为无柄盘菌Pezicula sp.。开展了乙酰胆碱酯酶抑制活性化合物的分离,从Pezicula sp. JR14乙酸乙酯提取物中分离到4个化合物,利用核磁共振及质谱技术将其鉴定为behenic acid (1)、himeic acid B (2)、secalonic acid A (3)和palmitic acid (4)。采用改进的Ellman比色法对分离的化合物进行活性检测,结果表明,himeic acid B (2)具有较强的乙酰胆碱酯酶抑制活性,其IC50为205μg/mL(0.64mmol/L)。  相似文献   

15.
The biotransformation of huperzine B (hupB), one of the characteristic bioactive constituents of the medicinal plant Huperzia serrata, by a fungal endophyte of the host plant was studied. One new compound, 8α,15α‐epoxyhuperzine B ( 1 ), along with two known oxygenated hupB analogs, 16‐hydroxyhuperzine B ( 2 ) and carinatumin B ( 3 ), was isolated and identified. The structures of all the isolates were deduced by spectroscopic methods including NMR, MS, IR, and UV spectra. The known compounds 2 and 3 were obtained from a microbial source for the first time. To the best of our knowledge, it is the first report on the microbial transformation of hupB and would facilitate further structural modification of hupB by chemo‐enzymatic method. In the LPS‐induced neuro‐inflammation injury assay, 8α,15α‐epoxyhuperzine B ( 1 ) exhibited moderate neuroprotective activity by increasing the viability of U251 cell lines with an EC50 of 40.1 nm .  相似文献   

16.
Huperzine A is isolated from Huperzia serrata and is used for treatment of Alzheimer’s disease, due to its low toxicity and long effective period. The decrease in H. serrata sources means that natural huperzine A cannot meet the needs of clinical therapy. In this study, >200 endophytic fungal strains were isolated from H. serrata, and screened using high-performance liquid chromatography. Strain ES026 produced huperzine A. Production was identified and quantified by liquid chromatography–tandem mass spectrometry, and the yield of huperzine A was 1 μg/g dried mycelium. ES026 strain was identified as Colletotrichum gloeosporioides by morphology, polymerase chain reaction with species-specific primers and rDNA internal transcribed spacer sequence. ES026 contributes to the breeding of cultivated strains with high yield of huperzine A. Meanwhile, the strain was suitable for the study of biosynthesis of huperzine A.  相似文献   

17.
从我国民间中药蛇足石杉(Huperzia serrata(Thunb.)Trey.)的全草的总碱部位分得3个石松生物碱,经光谱分析鉴定为11α-过氧羟基马尾杉碱乙(1)、7-过氧羟基马尾杉碱乙(2)和马尾杉碱乙(3).1和2为首次发现的过氧羟基取代的石松生物碱.  相似文献   

18.
One new fawcettimine-type alkaloid ( 1 ), one new miscellaneous-type alkaloid ( 2 ), four new lycodine-type alkaloids ( 3 – 6 ), and eight known ones ( 7 – 14 ) were isolated from the whole plants of Huperzia serrata. Their structures and absolute configurations were elucidated based on spectroscopic data, X-ray diffraction, ECD calculation and Mosher's method. Compound 1 was a rare C18N2-type Lycopodium alkaloid, possessing serratinine skeleton with an amide side chain in C-5. The absolute configuration of the 18-OH of compounds 4 – 6 were first determined by Mosher's method. Moreover, compounds 1 – 14 were assayed anti-acetylcholinesterase effect in vitro, and compound 7 showed significant anti-acetylcholinesterase activity with an IC50 value of 16.18±1.64 μM.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号